Friedreich's Ataxia Drug Market – Gene Therapy and Genetic Approaches
Market Overview The Friedreich's ataxia drug market is advancing rapidly as gene therapy and genetic approaches offer the potential for permanent correction of the frataxin deficiency that causes this progressive neurodegenerative disorder. Unlike symptomatic treatments or small molecules that merely modulate disease expression, gene therapy aims to deliver a functional frataxin gene to cardiac...
0 Commentarii 0 Distribuiri 8 Views 0 previzualizare
BuzzingAbout https://www.buzzingabout.com